Dead space estimates may not be independently associated with 28-day mortality in COVID-19 ARDS
Lieuwe D. J. Bos(Amsterdam Neuroscience), Lluís Blanch(Universitat Autònoma de Barcelona), Antonio Artigas(Instituto de Salud Carlos III), Luis Morales–Quinteros(Universitat Autònoma de Barcelona), David Kaufman(University of Virginia Children's Hospital), Ary Serpa Neto(The University of Melbourne), Michela Botta(Amsterdam University Medical Centers), Anissa M. Tsonas(Amsterdam UMC Location University of Amsterdam), Marcus J. Schultz(University of St.Gallen), Frederique Paulus(Amsterdam University Medical Centers)
Cited by 35
Related Papers
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
|Critical Care|2013|1.4k
Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis
|JAMA|2003|958
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
|Intensive Care Medicine|2023|855
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|737
Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study
|The Lancet Respiratory Medicine|2017|645